logo
Αρχική Σελίδα Ειδήσεις

εταιρικά νέα για Rebeads at BIONNOVA 2026: Innovation & Collaboration

Πιστοποίηση
ΚΙΝΑ Nanjing Rebece Biotechnology Co., Ltd. Πιστοποιήσεις
ΚΙΝΑ Nanjing Rebece Biotechnology Co., Ltd. Πιστοποιήσεις
Είμαι Online Chat Now
επιχείρηση Ειδήσεις
Rebeads at BIONNOVA 2026: Innovation & Collaboration
τα τελευταία νέα της εταιρείας για Rebeads at BIONNOVA 2026: Innovation & Collaboration

We were proud to participate in the 7th China Biopharma Innovators Forum & Exhibition (BIONNOVA 2026), held in Shanghai from April 22–23. The event brought together 300+ leading industry speakers, 260+ enterprises, and thousands of professionals to explore cutting-edge areas such as cell and gene therapy, antibody therapeutics, and nucleic acid drugs.

Rebeads Biotech showcased our comprehensive portfolio of magnetic bead solutions and advanced application cases at the exhibition. It was a great opportunity to demonstrate our technological expertise and innovation capabilities, while engaging in meaningful discussions with industry peers.

We sincerely thank everyone who visited our booth and shared valuable insights with our technical team. In return, we were pleased to present our product strengths and provide tailored solutions for diverse application needs.

The exhibition has come to a close, yet our innovation continues. Insights gained from BIONNOVA 2026 will further guide our efforts to address evolving market demands and accelerate innovation.

Rebeads Biotech remains dedicated to advancing magnetic bead technologies and delivering high-quality core solutions to the global life sciences community.

τα τελευταία νέα της εταιρείας για Rebeads at BIONNOVA 2026: Innovation & Collaboration  0 τα τελευταία νέα της εταιρείας για Rebeads at BIONNOVA 2026: Innovation & Collaboration  1

Χρόνος μπαρ : 2026-04-27 11:08:06 >> κατάλογος ειδήσεων
Στοιχεία επικοινωνίας
Nanjing Rebece Biotechnology Co., Ltd.

Υπεύθυνος Επικοινωνίας: Miss. Yammy

Τηλ.:: +8617712128819

Στείλετε το ερώτημά σας απευθείας σε εμάς (0 / 3000)